4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine.
about
4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaquesAdjuvantive effects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: different effects on cellular and humoral immunity.4-1BB ligand activates bystander dendritic cells to enhance immunization in transCD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individualsImmune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent.Role of novel type I interferon epsilon in viral infection and mucosal immunity.Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens.Decreased 4-1BB expression on HIV-specific CD4+ T cells is associated with sustained viral replication and reduced IL-2 production.TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy?Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity.Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity.Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors.The contextual role of TNFR family members in CD8(+) T-cell control of viral infections.Intrinsic 4-1BB signals are indispensable for the establishment of an influenza-specific tissue-resident memory CD8 T-cell population in the lung.CD137 ligand signaling enhances myelopoiesis during infections.Unique IL-13Rα2-based HIV-1 vaccine strategy to enhance mucosal immunity, CD8(+) T-cell avidity and protective immunity.
P2860
Q27314155-E37B483F-7361-4485-A733-8D23005900B1Q33624219-367B77DC-5FF4-4797-B282-FD383C134F46Q34628912-24037B9A-5360-454C-9FD1-276F451587A4Q34692141-904C9093-AA47-4F88-8283-39E9EEBC285CQ35987596-93717F46-2D30-44D9-925D-894F489A562FQ36346860-AD1086D7-CE13-4501-99EC-B8305CD45141Q36382421-E0B1A611-5052-4D74-BDD2-AF80D3CD08CCQ37387280-BDC2B741-FE89-46BF-9114-D2E9C610DD26Q37433321-5081945C-1A88-4368-B369-BC89F1E1C337Q37590335-96F8C942-6A7F-4736-8CC2-3BAF314E2731Q37727208-CF38C034-B46D-4F70-98A5-772B196B3583Q37932525-04671DD7-2BEE-4CCA-96AB-F101E033E547Q38129083-A6F30AAA-D697-440F-84B7-6E8F4B328DD0Q40386176-E8D691A6-0007-4033-A0CB-61D29007D55AQ45184626-300B0606-875E-401F-90D1-04A551C74E70Q46391524-90CCB997-8175-42CC-993F-D2C8CB6B22D7
P2860
4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
4-1BBL coexpression enhances H ...... poxvirus prime-boost vaccine.
@en
4-1BBL coexpression enhances H ...... poxvirus prime-boost vaccine.
@nl
type
label
4-1BBL coexpression enhances H ...... poxvirus prime-boost vaccine.
@en
4-1BBL coexpression enhances H ...... poxvirus prime-boost vaccine.
@nl
prefLabel
4-1BBL coexpression enhances H ...... poxvirus prime-boost vaccine.
@en
4-1BBL coexpression enhances H ...... poxvirus prime-boost vaccine.
@nl
P2093
P1433
P1476
4-1BBL coexpression enhances H ...... poxvirus prime-boost vaccine.
@en
P2093
Barbara E H Coupar
Charani Ranasinghe
David B Boyle
Edward M Bertram
Ian A Ramshaw
Jodie M Harrison
P304
P356
10.1016/J.VACCINE.2006.06.007
P407
P577
2006-06-22T00:00:00Z